Detail page

Knowledge Web

Person

Lukas Pekar (1990-)

Chemiker

Name	Lukas Pekar
Time	1990- (Date of birth and death)
Place	Flörsheim am Main (Geburtsort) Darmstadt (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Dr. rer. nat.
Profession	Chemiker (characteristic profession)
Related	Institut für Biochemie (Darmstadt)
Record type	Person
GND-Identifier	1257644238
Record ID	1257644238
Involved in show all Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats Antibody display technologies: selecting the cream of the crop Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Lukas Pekar (1990-)

Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features

Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features

Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity

NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats

Antibody display technologies: selecting the cream of the crop

Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection

Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance